IVVD
Invivyd, Inc.
Company overview
- Market capitalization
- $280.02M
- Employees
- 122
- Latest publication
- 2026-09-29
About Invivyd, Inc.
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14,285,000USD | 13,744,000USD | 17,207,000USD | 13,129,000USD | 11,786,000USD | 11,304,000USD | 13,820,000USD | 9,300,000USD |
| Research Development | 29,367,000USD | 30,731,000USD | 10,048,000USD | 8,046,000USD | 9,573,000USD | 10,641,000USD | 17,910,000USD | 57,850,000USD |
| Selling General Administrative | 29,465,000USD | 25,117,000USD | 18,574,000USD | 15,018,000USD | 16,588,000USD | 16,751,000USD | 14,415,000USD | 12,955,000USD |
| Total Operating Expenses | 60,105,000USD | 55,335,000USD | 28,622,000USD | 23,064,000USD | 26,161,000USD | 27,392,000USD | 32,325,000USD | 70,805,000USD |
| Operating Income | -45,820,000USD | -43,136,000USD | -12,555,000USD | -11,023,000USD | -15,060,000USD | -16,922,000USD | -19,229,000USD | -62,311,000USD |
| Total Other Income Expense Net | 1,427,000USD | 1,736,000USD | 1,485,000USD | 553,000USD | 400,000USD | 633,000USD | 786,000USD | 1,572,000USD |
| Income Before Tax | -44,393,000USD | -41,400,000USD | -11,070,000USD | -10,470,000USD | -14,660,000USD | -16,289,000USD | -18,443,000USD | -60,739,000USD |
| Income Tax Expense | 0USD | — | — | — | — | — | -480,724USD | — |
| Net Income | -44,393,000USD | -41,400,000USD | -11,070,000USD | -10,470,000USD | -14,660,000USD | -16,289,000USD | -18,443,000USD | -60,739,000USD |
| Cost Of Revenue | — | 1,545,000USD | 1,140,000USD | 1,088,000USD | 685,000USD | 834,000USD | 724,000USD | 806,000USD |
| Gross Profit | — | 12,199,000USD | 16,067,000USD | 12,041,000USD | 11,101,000USD | 10,470,000USD | 13,096,000USD | 8,494,000USD |
| Net Income From Continuing Ops | — | -41,400,000USD | -11,070,000USD | -10,470,000USD | -14,660,000USD | -16,289,000USD | -18,443,000USD | -60,739,000USD |
| Ebit | — | -43,136,000USD | -12,555,000USD | -10,470,000USD | -15,060,000USD | -16,922,000USD | -19,229,000USD | -62,311,000USD |
| Ebitda | — | -42,623,000USD | -12,120,000USD | -10,039,000USD | -14,557,000USD | -16,184,000USD | -17,713,000USD | -61,752,000USD |
| Depreciation And Amortization | — | 513,000USD | 435,000USD | 431,000USD | 503,000USD | 738,000USD | 1,516,000USD | 559,000USD |
| Reconciled Depreciation | — | 513,000USD | 435,000USD | 431,000USD | 503,000USD | 738,000USD | 1,516,000USD | 559,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 53,426,000USD | 25,384,000USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 3,747,000USD | 1,618,000USD | 2,028,000USD | 462,000USD | 1,000USD | — |
| Gross Profit | 49,679,000USD | 23,766,000USD | -2,028,000USD | -462,000USD | -1,000USD | — |
| Research Development | 38,308,000USD | 137,254,000USD | 158,658,000USD | 179,214,000USD | 182,891,000USD | 106,486,303USD |
| Selling General Administrative | 66,931,000USD | 63,388,000USD | 49,125,000USD | 47,044,000USD | 36,517,000USD | — |
| Total Operating Expenses | 105,239,000USD | 200,642,000USD | 212,758,000USD | 248,031,000USD | 226,908,000USD | 111,989,162USD |
| Operating Income | -55,560,000USD | -176,876,000USD | -212,758,000USD | -248,031,000USD | -226,908,000USD | -111,989,162USD |
| Income Before Tax | -52,489,000USD | -169,925,000USD | -198,643,000USD | -241,317,000USD | -226,790,000USD | -111,975,447USD |
| Net Income | -52,489,000USD | -169,925,000USD | -198,643,000USD | -241,317,000USD | -226,790,000USD | -111,975,447USD |
| Net Income From Continuing Ops | -52,489,000USD | -169,925,000USD | -169,563,000USD | -241,317,000USD | -226,790,000USD | — |
| Ebit | -55,560,000USD | -176,876,000USD | -207,783,000USD | -226,258,000USD | -219,408,000USD | -108,530,436USD |
| Ebitda | -53,453,000USD | -173,763,000USD | -205,755,000USD | -225,796,000USD | -219,407,000USD | -65,327,000USD |
| Depreciation And Amortization | 2,107,000USD | 3,113,000USD | 2,028,000USD | 462,000USD | 1,000USD | 43,203,436USD |
| Reconciled Depreciation | 2,107,000USD | 3,113,000USD | 1,718,000USD | 462,000USD | 1,000USD | — |
| Total Other Income Expense Net | 3,071,000USD | 6,951,000USD | 14,115,000USD | 6,714,000USD | 118,000USD | 13,715USD |
| Unclassified Operating Expenses | — | — | 4,975,000USD | 21,773,000USD | 7,500,000USD | 5,502,859USD |
| Interest Expense | — | — | — | 43,084,000USD | 14,999,000USD | — |
| Income Tax Expense | — | — | — | -6,714,000USD | 7,499,000USD | -43,203USD |
| Non Operating Income Net Other | — | — | — | 6,714,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -241,317,000USD | -226,790,000USD | -111,975,447USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 218,883,000USD | 241,742,000USD | 276,883,000USD | 139,158,000USD | 89,138,000USD | 103,744,000USD | 129,515,000USD | 161,922,000USD |
| Cash And Equivalents | 160,080,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 182,112,000USD | 204,915,000USD | 247,467,000USD | 109,769,000USD | 59,281,000USD | 75,825,000USD | 100,681,000USD | 151,101,000USD |
| Other Current Assets | 10,810,000USD | -16,338,000USD | -18,640,000USD | 14,950,000USD | 15,133,000USD | 18,552,000USD | 20,163,000USD | 8,551,000USD |
| Other Non Current Assets | 1,176,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 37,803,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 31,028,000USD | 31,658,000USD | 34,163,000USD | 44,496,000USD | 44,451,000USD | 49,595,000USD | 61,976,000USD | 78,542,000USD |
| Other Current Liabilities | 71,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 181,080,000USD | 203,050,000USD | 241,540,000USD | 93,068,000USD | 42,789,000USD | 54,149,000USD | 67,539,000USD | 83,161,000USD |
| Total Equity Including Noncontrolling Interest | 181,080,000USD | — | — | — | — | — | — | — |
| Net Receivables | 11,222,000USD | 11,648,000USD | 13,919,000USD | 9,852,000USD | 8,809,000USD | 8,753,000USD | 11,169,000USD | 8,614,000USD |
| Property Plant Equipment Net | 10,250,000USD | 10,219,000USD | 3,807,000USD | 3,988,000USD | 4,402,000USD | 2,476,000USD | 2,893,000USD | 3,369,000USD |
| Accounts Payable | 9,486,000USD | 2,022,000USD | 13,744,000USD | 18,104,000USD | 18,051,000USD | 8,739,000USD | 10,448,000USD | 17,707,000USD |
| Short Term Debt | 1,616,000USD | 1,592,000USD | 1,314,000USD | 1,083,000USD | 1,067,000USD | 894,000USD | 1,304,000USD | 1,414,000USD |
| Common Stock | 29,000USD | 28,000USD | 28,000USD | 22,000USD | 12,000USD | 12,000USD | 12,000USD | 12,000USD |
| Retained Earnings | -1,040,276,000USD | -995,883,000USD | -954,483,000USD | -943,413,000USD | -932,943,000USD | -918,283,000USD | -901,994,000USD | -883,551,000USD |
| Accumulated Other Comprehensive Income | -35,000USD | -37,000USD | -41,000USD | -40,999USD | -39,000USD | -13,000USD | -5,000USD | -18,000USD |
| Total Liab | — | 38,692,000USD | 35,343,000USD | 46,090,000USD | 46,349,000USD | 49,595,000USD | 61,976,000USD | 78,761,000USD |
| Other Current Liab | — | 28,044,000USD | 19,105,000USD | 25,309,000USD | 25,333,000USD | 39,962,000USD | 50,224,000USD | 59,421,000USD |
| Capital Stock | — | 28,000USD | 28,000USD | 22,000USD | 12,000USD | 12,000USD | 12,000USD | 12,000USD |
| Cash | — | 184,153,000USD | 226,689,000USD | 84,967,000USD | 34,905,000USD | 48,078,000USD | 69,349,000USD | 106,869,000USD |
| Cash And Short Term Investments | — | 184,153,000USD | 226,689,000USD | 84,967,000USD | 34,905,000USD | 48,078,000USD | 69,349,000USD | 106,869,000USD |
| Net Debt | — | -175,527,000USD | -224,195,000USD | -82,290,000USD | -31,940,000USD | -47,184,000USD | -68,045,000USD | -105,236,000USD |
| Short Long Term Debt Total | — | 8,626,000USD | 2,494,000USD | 2,677,000USD | 2,965,000USD | 894,000USD | 1,304,000USD | 1,633,000USD |
| Inventory | — | 25,452,000USD | 25,499,000USD | 429,000USD | 434,000USD | 442,000USD | 25,907,000USD | 27,067,000USD |
| Property Plant Equipment Gross | — | 10,219,000USD | 3,807,000USD | 3,988,000USD | 4,402,000USD | 2,476,000USD | 2,893,000USD | 3,369,000USD |
| Common Stock Shares Outstanding | — | 309,670,101shares | 172,212,902shares | 170,169,865shares | 120,016,132shares | 119,883,479shares | 118,555,073shares | 119,495,284shares |
| Non Current Assets Total | — | 36,827,000USD | 29,416,000USD | 29,389,000USD | 29,857,000USD | 27,919,000USD | 28,834,000USD | 10,821,000USD |
| Non Current Liabilities Total | — | 7,034,000USD | 1,180,000USD | 1,594,000USD | 1,898,000USD | 0USD | 0USD | 219,000USD |
| Non Currrent Assets Other | — | 26,608,000USD | 25,609,000USD | 25,401,000USD | 25,455,000USD | 25,443,000USD | 25,941,000USD | 7,452,000USD |
| Net Working Capital | — | 173,257,000USD | 213,304,000USD | 65,273,000USD | 14,830,000USD | 26,230,000USD | 38,705,000USD | 72,559,000USD |
| Unclassified Current Assets | — | -16,338,000USD | -18,640,000USD | — | — | — | -25,907,000USD | — |
| Unclassified Non Current Liabilities | — | 7,034,000USD | 1,180,000USD | 1,594,000USD | 1,898,000USD | — | — | — |
| Unclassified Equity | — | 1,198,914,000USD | 1,196,008,000USD | 1,036,477,999USD | 975,747,000USD | 972,421,000USD | 969,514,000USD | 966,706,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 276,883,000USD | 129,515,000USD | 229,181,000USD | 383,167,000USD | 620,091,000USD | 117,382,000USD |
| Other Current Assets | -18,640,000USD | 20,163,000USD | 23,307,000USD | 4,549,000USD | 25,064,000USD | 2,394,000USD |
| Total Liab | 35,343,000USD | 61,976,000USD | 51,713,000USD | 27,197,000USD | 62,072,000USD | 182,631,000USD |
| Total Stockholder Equity | 241,540,000USD | 67,539,000USD | 177,468,000USD | 355,970,000USD | 558,019,000USD | -65,249,000USD |
| Other Current Liab | 19,105,000USD | 50,224,000USD | 40,895,000USD | 21,955,000USD | 56,277,000USD | 4,919,000USD |
| Common Stock | 28,000USD | 12,000USD | 11,000USD | 11,000USD | 11,000USD | 1,000USD |
| Capital Stock | 28,000USD | 12,000USD | 11,000USD | 11,000USD | 11,000USD | 89,707,000USD |
| Retained Earnings | -954,483,000USD | -901,994,000USD | -732,069,000USD | -533,426,000USD | -292,109,000USD | -65,319,000USD |
| Cash | 226,689,000USD | 69,349,000USD | 200,641,000USD | 92,076,000USD | 542,224,000USD | 114,988,000USD |
| Cash And Short Term Investments | 226,689,000USD | 69,349,000USD | 200,641,000USD | 371,991,000USD | 591,418,000USD | 114,988,000USD |
| Total Current Assets | 247,467,000USD | 100,681,000USD | 224,881,000USD | 376,917,000USD | 616,711,000USD | 117,382,000USD |
| Total Current Liabilities | 34,163,000USD | 61,976,000USD | 50,291,000USD | 25,031,000USD | 62,060,000USD | 13,072,000USD |
| Net Debt | -224,195,000USD | -68,045,000USD | -198,476,000USD | -88,352,000USD | -542,224,000USD | -114,988,000USD |
| Short Term Debt | 1,314,000USD | 1,304,000USD | 1,443,000USD | 1,559,000USD | — | — |
| Short Long Term Debt Total | 2,494,000USD | 1,304,000USD | 2,165,000USD | 3,724,000USD | — | — |
| Net Receivables | 13,919,000USD | 11,169,000USD | 933,000USD | 377,000USD | 229,000USD | — |
| Inventory | 25,499,000USD | 25,907,000USD | -1,575,000USD | -377,000USD | -229,000USD | — |
| Accounts Payable | 13,744,000USD | 10,448,000USD | 7,953,000USD | 1,517,000USD | 5,783,000USD | 8,153,000USD |
| Property Plant Equipment Net | 3,807,000USD | 2,893,000USD | 4,125,000USD | 6,059,000USD | 83,000USD | 0USD |
| Property Plant Equipment Gross | 3,807,000USD | 2,893,000USD | 4,125,000USD | 6,059,000USD | 83,000USD | — |
| Accumulated Other Comprehensive Income | -41,000USD | -5,000USD | -13,000USD | -272,000USD | -8,000USD | 0USD |
| Common Stock Shares Outstanding | 172,212,902shares | 118,555,073shares | 109,526,053shares | 108,268,289shares | 110,782,909shares | 111,245,660shares |
| Non Current Assets Total | 29,416,000USD | 28,834,000USD | 4,300,000USD | 6,250,000USD | 3,380,000USD | 0USD |
| Non Current Liabilities Total | 1,180,000USD | 0USD | 1,422,000USD | 2,166,000USD | 12,000USD | 169,559,000USD |
| Non Currrent Assets Other | 25,609,000USD | 25,941,000USD | 175,000USD | 191,000USD | 3,297,000USD | — |
| Net Working Capital | 213,304,000USD | 38,705,000USD | 174,590,000USD | 351,886,000USD | 554,651,000USD | 104,310,000USD |
| Unclassified Current Assets | -18,640,000USD | -25,907,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | 1,180,000USD | — | — | — | — | 169,537,000USD |
| Unclassified Equity | 1,196,008,000USD | 969,514,000USD | 909,528,000USD | 889,646,000USD | 850,114,000USD | -89,638,000USD |
| Short Term Investments | — | — | 0USD | 279,915,000USD | 49,194,000USD | 0USD |
| Non Current Liabilities Other | — | — | 700,000USD | 2,166,000USD | 12,000USD | 11,000USD |
| Other Liab | — | — | — | 1,000USD | 12,000USD | 11,000USD |
| Other Assets | — | — | — | 191,000USD | 3,297,000USD | — |
| Net Tangible Assets | — | — | — | 355,970,000USD | 558,019,000USD | -65,249,000USD |
| Unclassified Non Current Assets | — | — | — | — | -3,297,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 5,592,000USD |
| Other Non Cash Items | -7,000USD |
| Change To Account Receivables | 2,697,000USD |
| Change To Inventory | 108,000USD |
| Change To Liabilities | -3,154,000USD |
| Change In Working Capital | -6,237,000USD |
| Operating Cash Flow | -84,717,000USD |
| Capital Expenditures | -1,236,000USD |
| Investing Cash Flow | -1,236,000USD |
| Financing Cash Flow | 19,344,000USD |
| Change In Cash | -66,609,000USD |
| End Cash Flow | 160,080,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -41,400,000USD | -11,070,000USD | -10,470,000USD | -14,660,000USD | -16,289,000USD | -18,443,000USD | -60,739,000USD | -47,247,000USD |
| Depreciation | 513,000USD | 435,000USD | 431,000USD | 503,000USD | 738,000USD | 1,516,000USD | 559,000USD | 514,000USD |
| Stock Based Compensation | 2,697,000USD | 2,564,000USD | 3,073,000USD | 3,180,000USD | 2,826,000USD | 3,057,000USD | 2,863,000USD | 8,489,000USD |
| Other Non Cash Items | 2,751,000USD | 2,000USD | 205,000USD | 91,000USD | — | 3,057,000USD | -4,374,000USD | 8,489,000USD |
| Change To Account Receivables | 2,221,000USD | -4,068,000USD | -1,360,000USD | -254,000USD | 2,345,000USD | -2,752,000USD | -5,266,000USD | -2,888,000USD |
| Change To Inventory | 47,000USD | -352,000USD | 50,000USD | -13,000USD | -58,000USD | -1,498,000USD | -20,755,000USD | -2,532,000USD |
| Change In Working Capital | -3,576,000USD | -7,386,000USD | -1,489,000USD | -2,415,000USD | -8,404,000USD | -23,740,000USD | 16,249,000USD | -3,355,000USD |
| Total Cash From Operating Activities | -41,712,000USD | -15,455,000USD | -8,250,000USD | -13,301,000USD | -21,129,000USD | -37,610,000USD | -41,068,000USD | -41,599,000USD |
| Capital Expenditures | -726,000USD | 0USD | 0USD | -11,000USD | -144,000USD | -5,000USD | -5,000USD | 0USD |
| Free Cash Flow | -42,438,000USD | -15,455,000USD | -8,250,000USD | -13,312,000USD | -21,273,000USD | -37,605,000USD | -41,073,000USD | -41,599,000USD |
| Total Cashflows From Investing Activities | -726,000USD | — | — | -11,000USD | -144,000USD | 5,000USD | -5,000USD | — |
| Total Cash From Financing Activities | -98,000USD | 157,177,000USD | 58,312,000USD | 131,000USD | 10,000USD | 77,000USD | 61,000USD | 92,000USD |
| Sale Purchase Of Stock | -231,000USD | — | 56,000USD | — | 44,000USD | 32,000USD | 191,000USD | — |
| Change In Cash | -42,536,000USD | 141,722,000USD | 50,062,000USD | -13,173,000USD | -21,271,000USD | -37,520,000USD | -41,012,000USD | -41,507,000USD |
| Begin Period Cash Flow | 226,689,000USD | 84,967,000USD | 34,905,000USD | 48,078,000USD | 69,349,000USD | 106,869,000USD | 147,881,000USD | 189,388,000USD |
| End Period Cash Flow | 184,153,000USD | 226,689,000USD | 84,967,000USD | 34,905,000USD | 48,078,000USD | 69,349,000USD | 106,869,000USD | 147,881,000USD |
| Unclassified Operating Cash Flow | -2,697,000USD | — | — | — | — | -3,057,000USD | 4,374,000USD | -8,489,000USD |
| Issuance Of Capital Stock | — | 157,402,000USD | 58,532,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Investments | — | — | 0USD | -11,000USD | -144,000USD | 5,000USD | -5,000USD | 0USD |
| Other Cashflows From Financing Activities | — | — | -220,000USD | — | -34,000USD | 39,362,000USD | 61,000USD | 92,000USD |
| Unclassified Financing Cash Flow | — | — | 58,476,000USD | — | — | -39,317,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -52,489,000USD | -169,925,000USD | -198,643,000USD | -241,317,000USD | -226,790,000USD | -65,319,000USD |
| Depreciation | 2,107,000USD | 3,113,000USD | 2,028,000USD | 462,000USD | 1,000USD | 1,000USD |
| Stock Based Compensation | 11,643,000USD | 19,788,000USD | 18,685,000USD | 21,648,000USD | 17,764,000USD | 266USD |
| Other Non Cash Items | 298,000USD | 19,788,000USD | -1,122,000USD | 15,350,000USD | 1,496,000USD | 40,070,000USD |
| Change To Account Receivables | -3,337,000USD | -10,906,000USD | 0USD | — | — | — |
| Change To Inventory | -373,000USD | -24,889,000USD | 0USD | — | — | — |
| Change In Working Capital | -19,694,000USD | -23,467,000USD | 5,888,000USD | -16,130,000USD | 22,793,000USD | 10,678,000USD |
| Total Cash From Operating Activities | -58,135,000USD | -170,491,000USD | -173,164,000USD | -219,987,000USD | -184,736,000USD | -14,571,000USD |
| Capital Expenditures | -155,000USD | -140,000USD | -615,000USD | -1,705,000USD | -84,000USD | -84,000USD |
| Free Cash Flow | -58,290,000USD | -170,631,000USD | -173,779,000USD | -221,692,000USD | -184,820,000USD | -14,571,000USD |
| Total Cashflows From Investing Activities | -155,000USD | -140,000USD | 280,684,000USD | -230,667,000USD | -50,711,000USD | -50,711,000USD |
| Total Cash From Financing Activities | 215,630,000USD | 39,331,000USD | 1,045,000USD | 506,000USD | 662,683,000USD | 129,559,000USD |
| Sale Purchase Of Stock | -633,000USD | 223,000USD | -1,000USD | -4,000USD | -2,000USD | -3,000USD |
| Issuance Of Capital Stock | 215,934,000USD | 39,285,000USD | 0USD | 0USD | 666,068,000USD | — |
| Change In Cash | 157,340,000USD | -131,292,000USD | 108,565,000USD | -450,148,000USD | 427,236,000USD | 114,988,000USD |
| Begin Period Cash Flow | 69,349,000USD | 200,641,000USD | 92,076,000USD | 542,224,000USD | 114,988,000USD | — |
| End Period Cash Flow | 226,689,000USD | 69,349,000USD | 200,641,000USD | 92,076,000USD | 542,224,000USD | 114,988,000USD |
| Unclassified Financing Cash Flow | 216,263,000USD | 39,062,000USD | — | — | 330,907,000USD | — |
| Investments | — | -140,000USD | 63,953,000USD | -228,962,000USD | -50,627,000USD | -50,627,000USD |
| Other Cashflows From Financing Activities | — | 46,000USD | 1,046,000USD | 510,000USD | 331,778,000USD | 129,559,000USD |
| Unclassified Operating Cash Flow | — | -19,788,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | 217,346,000USD | — | — | — |
| Change To Liabilities | — | — | — | -39,128,000USD | -2,370,000USD | 13,976,574USD |
| Cash And Cash Equivalents Changes | — | — | — | -450,148,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | -228,962USD | -50,627USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.